Filing Flows › Bio-Techne (TECH) › Gross margin
Bio-Techne (TECH) gross margin by quarter
Bio-Techne's gross margin was 65.6% in Q1 FY27 (first quarter fiscal 2027), -0.2 pts from Q4 FY26. Over the last 6 quarters it ranged from 64.6% (Q2 FY26) to 67.9% (Q3 FY25).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | 65.6% | -0.2 pts | -0.0 pts |
| Q4 FY26 | 65.8% | -1.1 pts | — |
| Q3 FY26 | 66.9% | +2.2 pts | -1.0 pts |
| Q2 FY26 | 64.6% | -1.0 pts | — |
| Q1 FY26 | 65.6% | -2.2 pts | — |
| Q3 FY25 | 67.9% | — | — |
Q1 FY27 at a glance
Bio-Techne, Q1 FY27: revenue $300M (+5% year over year), operating margin 12.2%, net earnings $28.3M, operating cash flow $73.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bio-Techne's gross margin?
Bio-Techne's gross margin was 65.6% in Q1 FY27 (first quarter fiscal 2027), -0.2 pts from Q4 FY26.
How has Bio-Techne's gross margin changed?
Over the last 6 quarters it ranged from 64.6% (Q2 FY26) to 67.9% (Q3 FY25).